Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for ...

As Hurricane Milton approaches the Gulf Coast, the American Lung Association has released critical health guidance for ...

Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) ...

Respiratory viruses can remain hidden in immune cells in the lungs long after the initial symptoms of an infection have ...

Rural women with COPD face rising mortality rates, while urban women and men see declines. A new study highlights the social ...

Study reveals that COVID-19 significantly increases the risk of chronic fatigue syndrome, with specific populations, such as ...

On Sept 17, 2024, tobacco giant Philip Morris International (PMI) announced that it was selling Vectura at an enormous loss. Vectura, a pharmaceutical company that specialises in inhaled medicines for ...

Dr. Christopher Stanley will serve as president of the new nonprofit subsidiary headquartered in Troy, which employs 150.